Company intelligence / Profile preview
Shepherd Therapeutics
Natick, Massachusetts, United Statesshepherd.bio ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Preclinical
01
Overview
Shepherd Therapeutics uses a proprietary AI-driven platform to identify, develop, or partner on innovative therapies for rare cancers. As of the last available reports, it had several programs in preclinical or early clinical development but no approved products. The company leverages relationships with disease foundations and academic labs to source high-potential translational science targeting underserved cancer populations.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (e.g., pyrvinium pamoate)Monoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
ACC Research Foundation (collaboration/engagement)Harvard Venture Incubation Program (investor/incubator)Other biopharma companies seeking expansion into rare/orphan indications via partnership/licensing structures
Beyond the preview
Go deeper on Shepherd Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shepherd Therapeutics.